Botamedi is a Health Care and Pharmaceutical startup that was founded in 2001. The company recently secured a significant KRW802.20B Series B investment on 23 March 2022 from DWS Group. This investment reflects a strong interest from investors in the potential of Botamedi's products and services. With this latest funding, Botamedi is well-positioned to further develop its innovative solutions and expand its presence in the market. The company's focus on the health care and pharmaceutical industries presents promising opportunities for growth and impact within these sectors.
General Information
BounceWatch is an independent company data service, not affiliated with Botamedi. To contact Botamedi, visit botamedi.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Botamedi compare?
A PDF of Botamedi and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Botamedi soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Health Care
About Botamedi
Funding Rounds & Investors (1)
View AllFAQ About Botamedi
We're actively collecting intelligence on Botamedi.
Source: BounceWatch company record for Botamedi, https://bouncewatch.com/company/botamedi, updated 12 September 2024. When citing, please name BounceWatch and link this page.